» Articles » PMID: 7751034

Reduced Lysis by CD8+ Cytotoxic T Cells in Mixed Lymphocyte Reactions Induced Via CD4+ T Cells Exposed to Chemically Modified Antigen Presenting Cells

Overview
Journal Immunology
Date 1995 Mar 1
PMID 7751034
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The resistance by T lymphocytes to activation by antigen (anergy) is well documented for CD4+ T-helper (Th) cells, although less is known about CD8+ cytotoxic T lymphocytes (CTL). One widely used method of inducing anergy of CD4+Th is presentation of antigen by ECDI (1-ethyl-3-(3-dimethylamino-propyl)carbodiimide)-fixed antigen-presenting cells (APCs). We report here that in murine mixed lymphocyte reactions (MLRs), a marked reduction in detected cytotoxicity (which is mediated predominantly by CD8+ CTL) occurs on day 7 if the bulk cultures are restimulated 2 days previously with ECDI-fixed allogeneic splenocytes. No differences were seen between untreated cultures on days 5 and 7, or on day 7 of cultures to which were added unfixed allogeneic splenocytes, fixed or unfixed syngeneic splenocytes, or 'third-party' allogeneic splenocytes, 2 days previously. The effect is not mediated directly on CD8+ cells, since MLRs depleted of CD4+ cells immediately prior to exposure to fixed allogeneic splenocytes fail to show reduced lysis. On the other hand, reduced lysis did occur if CD4+ cells, purified from the MLRs on day 4, were exposed to ECDI-fixed allogeneic splenocytes and then returned to MLRs previously depleted of CD4+ cells. Moreover the effect is overcome using exogenous interleukin-2 (IL-2). We propose that CD4+ cells, restimulated by a regimen shown previously to induce their anergy, can cause a reduction in CD(8+)-mediated cytotoxicity in MLRs.

Citing Articles

Monocyte-Derived Suppressor Cells in Transplantation.

Ochando J, Conde P, Bronte V Curr Transplant Rep. 2015; 2(2):176-183.

PMID: 26301174 PMC: 4541698. DOI: 10.1007/s40472-015-0054-9.


Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells.

McCarthy D, Bryant J, Galvin J, Miller S, Luo X Am J Transplant. 2015; 15(6):1475-83.

PMID: 25807873 PMC: 4439351. DOI: 10.1111/ajt.13237.

References
1.
Van Pel A, De Plaen E, Boon T . Selection of highly transfectable variant from mouse mastocytoma P815. Somat Cell Mol Genet. 1985; 11(5):467-75. DOI: 10.1007/BF01534840. View

2.
Jenkins M, Schwartz R . Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med. 1987; 165(2):302-19. PMC: 2188516. DOI: 10.1084/jem.165.2.302. View

3.
GORER P . Studies in antibody response of mice to tumour inoculation. Br J Cancer. 1950; 4(4):372-9. PMC: 2007731. DOI: 10.1038/bjc.1950.36. View

4.
Lombardi G, Sidhu S, Batchelor R, Lechler R . Anergic T cells as suppressor cells in vitro. Science. 1994; 264(5165):1587-9. DOI: 10.1126/science.8202711. View

5.
Kuwano K, Ono S, Arai S . Immobilized anti-TCR mAb induces split functions in a CD8+ CTL clone. Cell Immunol. 1994; 153(1):105-16. DOI: 10.1006/cimm.1994.1009. View